Abstract
Invasive group A streptococcal (GAS) infections have a broad and evolving clinical spectrum, associated with various GAS genotypes and/or virulence factors that are only poorly described in children. We aimed to assess the clinical and molecular characteristics of invasive GAS infections in 28 children admitted from 2000 to 2007 at a large French pediatric tertiary care center. The GAS isolates were characterized molecularly by emm-typing and by the determination of the main virulence factors: speA, speB, speC, smeZ-1, ssa, sic, and silC. The median age of the children was 2.9 years. Osteoarticular infection (OAI) was the main clinical manifestation (n = 15/28, 53%). emm-1 predominated (n = 10/28), followed by emm-12, 3, and 4. No significant correlation was found between emm type and clinical manifestations, but emm-1 predominated in cases of OAI (n = 7/15) and was associated with speA, speB, smeZ-1, and sic virulence factor genes. In this pediatric study, we describe a predominance of OAI associated with emm-1 GAS. Further larger international pediatric studies, including host immunity evaluation, are needed in order to better assess the pathogenesis of GAS infection in children.
References
Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470–511
Cimolai N, Trombley C, Adderley RJ, Tredwell SJ (1992) Invasive Streptococcus pyogenes infections in children. Can J Public Health 83(3):230–233
Davies HD, Matlow A, Scriver SR, Schlievert P, Lovgren M, Talbot JA et al (1994) Apparent lower rates of streptococcal toxic shock syndrome and lower mortality in children with invasive group A streptococcal infections compared with adults. Pediatr Infect Dis J 13(1):49–56
Mulla ZD (2007) Clinical and epidemiologic features of invasive group A streptococcal infections in children. Pediatr Int 49(3):355–358
Beall B, Facklam R, Thompson T (1996) Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34(4):953–958
Schmitz FJ, Beyer A, Charpentier E, Normark BH, Schade M, Fluit AC et al (2003) Toxin-gene profile heterogeneity among endemic invasive European group A streptococcal isolates. J Infect Dis 188(10):1578–1586
Bidet P, Courroux C, Salgueiro C, Carol A, Mariani-Kurkdjian P, Bonacorsi S et al (2007) Molecular epidemiology of the sil streptococcal invasive locus in group A streptococci causing invasive infections in French children. J Clin Microbiol 45(6):2002–2004
Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalén C et al (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis 45(4):450–458
Rivera A, Rebollo M, Miró E, Mateo M, Navarro F, Gurguí M et al (2006) Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J Med Microbiol 55(Pt 8):1115–1123
Minodier P, Bidet P, Rallu F, Tapiero B, Bingen E, Ovetchkine P (2009) Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children. Pediatr Infect Dis J 28(6):541–543
Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B et al (2008) Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 46(7):2359–2367
Lesko SM, O’Brien KL, Schwartz B, Vezina R, Mitchell AA (2001) Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella. Pediatrics 107(5):1108–1115
O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A et al (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000–2004. Clin Infect Dis 45(7):853–862
Factor SH, Levine OS, Harrison LH, Farley MM, McGeer A, Skoff T et al (2005) Risk factors for pediatric invasive group A streptococcal disease. Emerg Infect Dis 11(7):1062–1066
Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalén C (2005) The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 10(9):179–184
Stevens DL (1992) Invasive group A streptococcus infections. Clin Infect Dis 14(1):2–11
O’Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM et al (2002) Epidemiology of invasive group a streptococcus disease in the United States, 1995–1999. Clin Infect Dis 35(3):268–276
Vlaminckx BJ, van Pelt W, Schouls LM, van Silfhout A, Mascini EM, Elzenaar CP et al (2005) Long-term surveillance of invasive group A streptococcal disease in The Netherlands, 1994–2003. Clin Microbiol Infect 11(3):226–231
Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A et al (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47(4):1155–1165
Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC et al (2003) Site-specific manifestations of invasive group a streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol 41(11):4941–4949
McMillan DJ, Beiko RG, Geffers R, Buer J, Schouls LM, Vlaminckx BJ et al (2006) Genes for the majority of group a streptococcal virulence factors and extracellular surface proteins do not confer an increased propensity to cause invasive disease. Clin Infect Dis 43(7):884–891
Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL et al (2005) Macrolide-resistant Streptococcus pyogenes in the United States, 2002–2003. Clin Infect Dis 41(5):599–608
Tanz RR, Shulman ST, Shortridge VD, Kabat W, Kabat K, Cederlund E et al (2004) Community-based surveillance in the United States of macrolide-resistant pediatric pharyngeal group A streptococci during 3 respiratory disease seasons. Clin Infect Dis 39(12):1794–1801
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Henriet, S., Kaguelidou, F., Bidet, P. et al. Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center. Eur J Clin Microbiol Infect Dis 29, 341–346 (2010). https://doi.org/10.1007/s10096-009-0854-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-009-0854-x